Mangesh A Thorat

Summary

Publications

  1. ncbi What caused the decline in US breast cancer incidence?
    Mangesh A Thorat
    Translational Genomics Core at Indiana University, Indianapolis, IN 46202, USA
    Nat Clin Pract Oncol 5:314-5. 2008
  2. ncbi Revision surgery for breast cancer: single-institution experience
    Mangesh A Thorat
    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Cancer 113:2347-52. 2008
  3. ncbi Herceptin in early breast cancer: a call for judicious use
    Mangesh A Thorat
    Department of Surgical Oncology, Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai, Maharashtra
    Natl Med J India 18:315-7. 2005
  4. ncbi Tuning into the genetic orchestra using microarrays: limitations of DNA microarrays in clinical practice
    Mangesh Thorat
    Department of Surgical Oncology, Tata Memorial Hospital, Dr. E.Borges Marg, Parel, Mumbai, 400012, India
    Nat Clin Pract Oncol 3:E1. 2006
  5. ncbi Prostanoid receptor EP1 expression in breast cancer
    Mangesh A Thorat
    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Mod Pathol 21:15-21. 2008
  6. ncbi COX-2 expression does not correlate with microvessel density in breast cancer
    Mangesh A Thorat
    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Pathobiology 76:39-44. 2009
  7. ncbi Differential gene expression profiling of esophageal adenocarcinoma
    Zane T Hammoud
    Department of Surgery, Thoracic Surgery Division, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Thorac Cardiovasc Surg 137:829-34. 2009
  8. ncbi Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
    Yesim Gokmen-Polar
    Department of Medicine, Indiana University School of Medicine, Walther Hall, 980 W Walnut Street, C230, Indianapolis, IN 46202, USA
    Breast Cancer Res Treat 124:327-35. 2010
  9. ncbi Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model
    Kasi McCune
    Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Oncol Rep 24:1233-9. 2010
  10. ncbi Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
    Foluso O Ademuyiwa
    Department of Medicine, Indiana University, School of Medicine, Indianapolis, IN 46202, USA
    Mod Pathol 23:270-5. 2010

Collaborators

Detail Information

Publications20

  1. ncbi What caused the decline in US breast cancer incidence?
    Mangesh A Thorat
    Translational Genomics Core at Indiana University, Indianapolis, IN 46202, USA
    Nat Clin Pract Oncol 5:314-5. 2008
  2. ncbi Revision surgery for breast cancer: single-institution experience
    Mangesh A Thorat
    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Cancer 113:2347-52. 2008
    ..The possible detrimental impact of inadequate surgical intervention may be very large in India and in other low-resource settings...
  3. ncbi Herceptin in early breast cancer: a call for judicious use
    Mangesh A Thorat
    Department of Surgical Oncology, Tata Memorial Hospital, Dr E Borges Marg, Parel, Mumbai, Maharashtra
    Natl Med J India 18:315-7. 2005
  4. ncbi Tuning into the genetic orchestra using microarrays: limitations of DNA microarrays in clinical practice
    Mangesh Thorat
    Department of Surgical Oncology, Tata Memorial Hospital, Dr. E.Borges Marg, Parel, Mumbai, 400012, India
    Nat Clin Pract Oncol 3:E1. 2006
  5. ncbi Prostanoid receptor EP1 expression in breast cancer
    Mangesh A Thorat
    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Mod Pathol 21:15-21. 2008
    ..059). Expression of EP1 is frequently seen in human breast cancers. Nuclear expression of EP1 correlates with good prognosis markers like node negative status and PR expression...
  6. ncbi COX-2 expression does not correlate with microvessel density in breast cancer
    Mangesh A Thorat
    Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Pathobiology 76:39-44. 2009
    ..The exact mechanism of such action is not known and the clinical evidence of such interaction is weak. We studied COX-2 expression and microvessel density (MVD) in malignant breast tissues...
  7. ncbi Differential gene expression profiling of esophageal adenocarcinoma
    Zane T Hammoud
    Department of Surgery, Thoracic Surgery Division, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Thorac Cardiovasc Surg 137:829-34. 2009
    ....
  8. ncbi Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
    Yesim Gokmen-Polar
    Department of Medicine, Indiana University School of Medicine, Walther Hall, 980 W Walnut Street, C230, Indianapolis, IN 46202, USA
    Breast Cancer Res Treat 124:327-35. 2010
    ..Our study suggests the necessity for assessing the subcellular localization of PKCβII in breast cancer subtypes when evaluating the possible effectiveness of PKCβII-targeting agents...
  9. ncbi Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model
    Kasi McCune
    Department of Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Oncol Rep 24:1233-9. 2010
    ..In in vitro studies, PEITC depleted AldeFluor-positive putative stem/progenitor cells, which may partly be responsible for the delay in tumor initiation...
  10. ncbi Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
    Foluso O Ademuyiwa
    Department of Medicine, Indiana University, School of Medicine, Indianapolis, IN 46202, USA
    Mod Pathol 23:270-5. 2010
    ..To confirm these findings, further studies in a larger cohort of patients are warranted...
  11. ncbi Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet
    Kasi McCune
    Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Cancer Res 70:685-96. 2010
    ....
  12. ncbi FOXA1 expression in breast cancer--correlation with luminal subtype A and survival
    Sunil Badve
    Department of Pathology, Indiana University School of Medicine, Indianapolis, USA
    Clin Cancer Res 13:4415-21. 2007
    ..It segregates with genes that characterize the luminal subtypes in DNA microarray analyses. The utility of FOXA1 as a possible independent prognostic factor has not been determined in breast cancers...
  13. ncbi Radical and simple mastectomy
    Rajendra A Badwe
    N Engl J Med 347:2170-1; author reply 2170-1. 2002
  14. ncbi MRI breast screening
    Mangesh A Thorat
    Lancet 371:1415; author reply 1416. 2008
  15. ncbi Gene-signature-based prognostic tools in breast cancer: not yet
    Mangesh A Thorat
    Lancet 369:1428. 2007
  16. ncbi Radiation therapy for ductal carcinoma in situ: is it really worth it?
    Mangesh A Thorat
    J Clin Oncol 25:461-2; author reply 462. 2007
  17. ncbi Cancer immunotherapeutics: raising the ante
    Mangesh A Thorat
    Department of Surgical Oncology, Tata Memorial Hospital, Dr E Borges Marg, Mumbai, Maharashtra, India
    Natl Med J India 19:140-50. 2006
  18. ncbi Are there distinct lymphatic flow patterns in the Breast?
    Mangesh A Thorat
    Med Hypotheses 66:1040-1. 2006
  19. ncbi Sentinel-node biopsy in breast cancer
    Rajendra A Badwe
    N Engl J Med 349:1968-71; author reply 1968-71. 2003
  20. ncbi Should we undertake an MRI breast screening trial?
    Mangesh A Thorat
    Lancet 370:1902; author reply 1903-4. 2007